Sources

What MatchMedi cites, embeds, and links.

Source use is part of the safety model. Some sources can be embedded with attribution. Others are link-only until reuse terms are cleared.

Cancer source coverage

Which sources power each cancer page.

This table shows the source backbone for melanoma depth and the newer overview-only cancer pages. Overview pages are not treatment modules.

Cancer	Coverage	Registered sources	Next review need
Melanoma	Deep coverage	Melanoma Treatment (PDQ) - Patient Version Melanoma Treatment (PDQ) - Health Professional Version	Continue deepening melanoma while other cancer pages remain source-backed overviews.
Lung cancer	Source-backed overview	Non-Small Cell Lung Cancer Treatment (PDQ) - Patient Version	Add subtype and biomarker records only after citations and claim-audit entries are ready.
Breast cancer	Source-backed overview	Breast Cancer Treatment (PDQ) - Patient Version	Build subtype records only after receptor-status language and source licensing are audited.
Colorectal cancer	Source-backed overview	Colon Cancer Treatment (PDQ) - Patient Version	Add colon and rectal tracks separately once source-backed biomarker records are ready.
Leukemia	Source-backed overview	Adult Acute Myeloid Leukemia Treatment (PDQ) - Patient Version Adult Acute Lymphoblastic Leukemia Treatment (PDQ) - Patient Version Childhood Acute Lymphoblastic Leukemia Treatment (PDQ) - Patient Version Chronic Lymphocytic Leukemia Treatment (PDQ) - Patient Version Chronic Myeloid Leukemia Treatment (PDQ) - Patient Version	Build subtype-specific AML, ALL, CLL, and CML research records before adding any leukemia options explorer.
Leukemia / lymphoma	Source-backed overview	Adult Acute Myeloid Leukemia Treatment (PDQ) - Patient Version Adult Non-Hodgkin Lymphoma Treatment (PDQ) - Patient Version	Use /cancers/leukemia for leukemia. Split lymphoma into its own module next.
Pediatric solid tumors	Source-backed overview	NCI Childhood Cancers	Build pediatric-specific source map and reviewer pipeline before deep treatment pages.

open-embed

Melanoma Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary patient-facing source for melanoma overview and treatment categories.

Registered citations: 7

Open source

open-embed

Melanoma Treatment (PDQ) - Health Professional Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Professional detail source for mutation and treatment-option derivation.

Registered citations: 1

Open source

open-embed

Non-Small Cell Lung Cancer Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary source for the lung-cancer overview entry point.

Registered citations: 1

Open source

open-embed

Breast Cancer Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary source for the breast-cancer overview entry point.

Registered citations: 1

Open source

open-embed

Colon Cancer Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary source for the colorectal-cancer overview entry point.

Registered citations: 1

Open source

open-embed

Adult Acute Myeloid Leukemia Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Source for initial leukemia entry point; not a complete leukemia module.

Registered citations: 3

Open source

open-embed

Adult Acute Lymphoblastic Leukemia Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary patient-facing source for adult ALL overview and source mapping.

Registered citations: 1

Open source

open-embed

Childhood Acute Lymphoblastic Leukemia Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary patient-facing source for childhood ALL; pediatric leukemia needs separate handling.

Registered citations: 2

Open source

open-embed

Chronic Lymphocytic Leukemia Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary patient-facing source for CLL overview and source mapping.

Registered citations: 1

Open source

open-embed

Chronic Myeloid Leukemia Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary patient-facing source for CML overview and BCR-ABL/phase source mapping.

Registered citations: 1

Open source

open-embed

Chronic Myeloid Leukemia Treatment (PDQ) - Health Professional Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Professional source for CML treatment-context mapping, including TKI and transplant language.

Registered citations: 1

Open source

open-embed

Stem Cell and Bone Marrow Transplants for Cancer

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Patient-facing transplant source. Use for transplant process and risks, not to decide transplant fit.

Registered citations: 1

Open source

open-embed

Discontinuing Nilotinib in Patients with CML

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: context-only

Can support patient-facing summaries when attribution and context are shown.

Context source for treatment-free remission and careful monitoring after TKI discontinuation in selected CML patients.

Registered citations: 1

Open source

open-embed

Adult Non-Hodgkin Lymphoma Treatment (PDQ) - Patient Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Source for initial lymphoma entry point; not a complete lymphoma module.

Registered citations: 1

Open source

open-embed

Childhood Cancers

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Pediatric cancer entry source; deep pediatric pages require additional source mapping.

Registered citations: 1

Open source

open-embed

NCI Dictionary of Cancer Terms

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary glossary source.

Registered citations: 0

Open source

open-embed

Photodynamic Therapy to Treat Cancer

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary source for PDT as local light-activated treatment; does not make PDT a melanoma systemic-treatment claim.

Registered citations: 1

Open source

open-embed

Lasers to Treat Cancer

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary source for laser therapy as a local treatment and procedural tool; use carefully for melanoma only as local-modality context.

Registered citations: 1

Open source

open-embed

Hyperthermia to Treat Cancer

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Primary source for heat-based cancer treatment categories; emphasizes limited availability and use with other treatments.

Registered citations: 1

Open source

open-embed

NCI Drug Dictionary: Hyperbaric Oxygen

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: context-only

Can support patient-facing summaries when attribution and context are shown.

Context source for hyperbaric oxygen; patient pages must not present HBOT as proven melanoma treatment.

Registered citations: 1

Open source

open-embed

Cardiopulmonary Syndromes (PDQ) - Health Professional Version

National Cancer Institute

government-cancer-informationconfidence: highpatient claim: context-only

Can support patient-facing summaries when attribution and context are shown.

Supportive-care context for oxygen use in cancer-related dyspnea and hypoxemia; not a melanoma anti-cancer treatment source.

Registered citations: 1

Open source

open-embed

ClinicalTrials.gov API

National Library of Medicine

trial-registryconfidence: highpatient claim: context-only

Can support patient-facing summaries when attribution and context are shown.

Trial registry API used as secondary/fallback trial source.

Registered citations: 6

Open source

open-embed

PubMed

National Library of Medicine

peer-reviewed-paperconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Bibliographic source for peer-reviewed biomedical literature.

Registered citations: 1

Open source

link-only

KeChow Pharma

Shanghai KeChow Pharma

companyconfidence: mediumpatient claim: context-only

Link out and use carefully. Do not embed or quote heavily without clearer reuse rights.

Company source; use only for approval/availability context and verify against regulator/trial sources.

Registered citations: 1

Open source

open-embed

NCI Clinical Trials Search API

National Cancer Institute

trial-registryconfidence: highpatient claim: context-only

Can support patient-facing summaries when attribution and context are shown.

Primary cancer trial search source.

Registered citations: 4

Open source

terms-review

CIViC: Clinical Interpretation of Variants in Cancer

CIViC

peer-reviewed-paperconfidence: mediumpatient claim: context-only

Useful candidate source, but terms need review before embedding clinical text.

Open cancer variant evidence candidate. Verify current license before embedded quotation.

Registered citations: 0

Open source

open-embed

FDA Oncology Center of Excellence

U.S. Food and Drug Administration

regulatorconfidence: highpatient claim: yes

Can support patient-facing summaries when attribution and context are shown.

Drug approvals and labeling references.

Registered citations: 6

Open source

link-only

NCCN Guidelines for Patients

National Comprehensive Cancer Network

professional-guidelineconfidence: highpatient claim: context-only

Link out and use carefully. Do not embed or quote heavily without clearer reuse rights.

Link-only posture until reuse terms are cleared.

Registered citations: 0

Open source

terms-review

국가암정보센터

National Cancer Information Center Korea

government-cancer-informationconfidence: highpatient claim: yes

Useful candidate source, but terms need review before embedding clinical text.

Primary Korean source candidate. API reuse terms require review.

Registered citations: 3

Open source

link-only

China Center for Drug Evaluation

National Medical Products Administration

regulatorconfidence: highpatient claim: context-only

Link out and use carefully. Do not embed or quote heavily without clearer reuse rights.

Chinese regulator/drug evaluation source. Use for approval research and link out.

Registered citations: 0

Open source

link-only

National Medical Products Administration

China National Medical Products Administration

regulatorconfidence: highpatient claim: yes

Link out and use carefully. Do not embed or quote heavily without clearer reuse rights.

Chinese regulator source for drug approval and conditional marketing status.

Registered citations: 1

Open source

link-only

Chinese Clinical Trial Registry

trial-registryconfidence: mediumpatient claim: context-only

Link out and use carefully. Do not embed or quote heavily without clearer reuse rights.

China trial registry source.

Registered citations: 0

Open source

link-only

がん情報サービス

National Cancer Center Japan

government-cancer-informationconfidence: highpatient claim: context-only

Link out and use carefully. Do not embed or quote heavily without clearer reuse rights.

Japanese cancer information source; link primarily until reuse terms are reviewed.

Registered citations: 1

Open source

link-only

PMDA

Pharmaceuticals and Medical Devices Agency Japan

regulatorconfidence: highpatient claim: context-only

Link out and use carefully. Do not embed or quote heavily without clearer reuse rights.

Japan drug approval and safety information source.

Registered citations: 1

Open source

Source-use rules

Class	How we use it	Examples
open-embed	Use with attribution and last-checked dates in summaries.	NCI, FDA, ClinicalTrials.gov
link-only	Link out, but avoid embedding long or restricted content.	NCCN, PMDA, NMPA context
terms-review	Use sparingly until reuse terms are reviewed.	CIViC, KCIC API reuse

High confidence

Government, regulator, registry

Used for approval status, trial listings, and public cancer information.

Medium confidence

Context sources

Company pages or variant databases may provide leads, but need cross-checking.

Unresolved

Not for strong claims

If terms or exact records are unclear, they do not support strong treatment claims.